Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Wien Klin Wochenschr ; 127(19-20): 786-91, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26142170

ABSTRACT

BACKGROUND: This study aims to answer the question to which extent even very heavy nicotine-dependent smokers can benefit from a 3-week inpatient smoking cessation program. A particular focus lies on analyzing the positive effects, which go above and beyond normally anticipated health benefits. METHODS: This is a descriptive study observing 270 patients over a 1-year period consisting of recruitment, therapy, and two post-therapy follow-up visits at 6-month interval. Gender differences, changes in body weight, and factors relating to addiction and the nicotine withdrawal process are analyzed. In comparing successful participants-post-therapy nonsmokers-with less successful ones, our analysis identifies benefits and advantages an inpatient smoking cessation therapy can bring to even the heaviest smokers. RESULTS: At the 12-month post-therapy follow-up visit, 42.6% of participants were identified as nonsmokers. A total of 34.0% of participants took up smoking again. No data is available on the remaining participants. Nonsmokers experienced significant reduction in nicotine craving and withdrawal symptoms. In terms of body weight, increases were found in both, men and women, nonsmokers and smokers. CONCLUSION: Successful quitters fail to report of an unbearable strong desire to smoke. Such unfounded fear should be communicated. Weight gain remains an undesired side effect. Hence, it is crucial to diagnose individuals more prone to weight gain and offer coping strategies thus reducing the risk of developing obesity. Nevertheless, the outcome of the study should be an encouragement to also heavy smokers and empower them to undertake smoking cessation.


Subject(s)
Health Promotion/statistics & numerical data , Inpatients/statistics & numerical data , Smoking Cessation/statistics & numerical data , Smoking Prevention , Smoking/epidemiology , Tobacco Use Disorder/epidemiology , Adult , Age Distribution , Aged , Aged, 80 and over , Austria/epidemiology , Hospitalization , Humans , Middle Aged , Prevalence , Risk Factors , Sex Distribution , Treatment Outcome
2.
Int J Clin Pharmacol Ther ; 50(12): 867-72, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23036238

ABSTRACT

OBJECTIVE: The introduction of anti- tumor necrosis factor-alpha agents (TNF-inhibitors) offered new dimensions in symptom relief and alteration of disease progression for patients with Ankylosing Spondylitis (AS). In 2007, Infliximab, Etanercept and Adalimumab were approved for AS in Austria. Drug reimbursement data of 2007 were retrieved to evaluate frequency of prescription, preferred substance and data on switching therapies. METHODS: Data from eight health insurance funds covering 5.4 million insured people, which corresponds to 64% of the population, was analyzed by linking two databases, combining data on therapy of individual patients and their diagnosis. For those patients on TNF-inhibitors in 2007 reimbursement data from 2008 and 2009 were obtained, respectively. RESULTS: A total of 694 patients with AS on TNF inhibitors in 2007 were identified for data analysis. Yearly costs for TNF-inhibitors were highest for Adalimumab (14,399 € per patient) followed by Infliximab (11,685 € per patient) and Etanercept (10,184 € per patient). In first-time TNF-inhibitor prescriptions, Adalimumab was prescribed most often, with a tendency towards prescription of Adalimumab and Etanercept in the younger and Infliximab in the older population. In the first year of prescription, 12% of patients already switched from the initially prescribed drug to another substance with those started on Etanercept showing the lowest switching rate. One-year drug survival in our data was highest for Etanercept with 83% still on the drug after 1 year, followed by Infliximab and then Adalimumab, while two-year drug survival was also highest for Etanercept (58%), followed by Adalimumab and then Infliximab. CONCLUSIONS: Patients with Ankylosing Spondylitis starting on TNF-inhibiting therapy in Austria in 2007 were treated most often with Adalimumab, while Etanercept showed the lowest switching rate and the longest 1- and 2-year drug survival.


Subject(s)
Spondylitis, Ankylosing/drug therapy , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab , Adult , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Australia , Drug Costs , Etanercept , Female , Humans , Immunoglobulin G/therapeutic use , Infliximab , Male , Middle Aged , Receptors, Tumor Necrosis Factor/therapeutic use , Retrospective Studies , Time Factors
3.
J Orthop Res ; 25(10): 1317-24, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17557324

ABSTRACT

Because extrafibrillar water content dictates extrafibrillar osmolarity, we aimed to determine the influence of intra- and extrafibrillar fluid exchange on intradiscal pressures and stresses. As experimental results showed that extrafibrillar osmolarity affects intervertebral disc cell gene expression and crack propagation, quantification of the effects of changes in intra- and extrafibrillar fluid exchange is physiologically relevant. Therefore, our 3D osmoviscoelastic finite element (FE) model of the intervertebral disc was extended to include the intra- and extrafibrillar water differentiation. Two simulations were performed, one without intrafibrillar fluid and one with intrafibrillar fluid fraction as a function of the extrafibrillar osmotic pressure. The intrafibrillar fluid fraction as a function of the extrafibrillar osmotic pressure was exponentially fitted to human data and implemented into the model. Because of the low collagen content in the nucleus, no noticeable differences in intradiscal pressure estimation were observed. However, values of extrafibrillar osmolarity, hydrostatic pressure, and the total tissue stress calculated for the annulus were clearly different. Stresses, hydrostatic pressure, and osmolarity were underestimated when the intrafibrillar water value was neglected. As the loading increased, the discrepancies increased. In conclusion, the distribution of pressure and osmolarity in the disc is affected by intra- and extrafibrillar water exchange.


Subject(s)
Body Water/metabolism , Fibrillar Collagens/metabolism , Fluid Shifts/physiology , Intervertebral Disc/physiology , Models, Biological , Osmotic Pressure , Body Water/chemistry , Computer Simulation , Fibrillar Collagens/chemistry , Humans , Intervertebral Disc/chemistry , Mechanotransduction, Cellular/physiology , Osmolar Concentration , Stress, Mechanical , Weight-Bearing/physiology
4.
Eur Spine J ; 15 Suppl 3: S361-71, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16724211

ABSTRACT

Intervertebral discs have a primarily mechanical role in transmitting loads through the spine. The disc is subjected to a combination of elastic, viscous and osmotic forces; previous 3D models of the disc have typically neglected osmotic forces. The fibril-reinforced poroviscoelastic swelling model, which our group has recently developed, is used to compute the interplay of osmotic, viscous and elastic forces in an intervertebral disc under axial compressive load. The unloaded 3D finite element mesh equilibrates in a physiological solution, and exhibits an intradiscal pressure of about 0.2 MPa. Before and after axial loading the numerically simulated hydrostatic pressure compares well with the experimental ranges measured. Loading the disc decreased the height of the disc and results in an outward bulging of the outer annulus. Fiber stresses were highest on the most outward bulging on the posterior-lateral side. The osmotic forces resulted in tensile hoop stresses, which were higher than typical values in a non-osmotic disc. The computed axial stress profiles reproduced the main features of the stress profiles, in particular the characteristic posterior and anterior stress which were observed experimentally.


Subject(s)
Finite Element Analysis , Intervertebral Disc/anatomy & histology , Intervertebral Disc/physiology , Models, Anatomic , Spine/anatomy & histology , Spine/physiology , Cartilage/anatomy & histology , Cartilage/physiology , Computer Simulation , Elasticity , Humans , Osmotic Pressure , Stress, Mechanical , Viscosity , Weight-Bearing/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...